市場調査レポート
商品コード
1518350

がん情報システム市場:オファリング、用途、エンドユーザー別-2030年までの世界予測

Oncology Information Systems Market By Offering (Software Services) Application (Medical, Surgical, Radiology Oncology) End User (Hospital, Diagnostic Imaging Center, Cancer Care Center) - Global Forecast to 2030


出版日
ページ情報
英文 180 Pages
納期
5~7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
がん情報システム市場:オファリング、用途、エンドユーザー別-2030年までの世界予測
出版日: 2024年06月01日
発行: Meticulous Research
ページ情報: 英文 180 Pages
納期: 5~7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

がん情報システム市場は、2023~2030年のCAGRが7.4%で、2030年には44億5,000万米ドルに達すると予測されます。

本レポートでは、広範な2次調査と1次調査、市場シナリオの詳細な分析を経て、主要な業界促進要因、抑制要因、市場促進要因・課題の分析を提供しています。

この市場の成長は、がんの有病率の増加、がん治療におけるデジタル化の進展、がん治療費の削減ニーズの高まり、電子カルテ(EHR)の採用の増加、合理化された患者情報とデータ管理に対する需要の高まりが原動力となっています。

しかし、がん情報システムの高コストやデータのセキュリティとプライバシーに関する懸念が、この市場の成長を抑制しています。さらに、がん治療への精密医療の統合と新興国におけるその可能性の高まりは、この市場の参入企業に大きな成長機会をもたらすと期待されています。

しかし、がん情報システムの導入と実装に対する障壁と、がん情報システムを使用するためのトレーニングと教育に対する追加要件は、市場の成長を制限する主要課題です。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブ概要

第4章 市場洞察

  • 市場概要
  • 促進要因
    • がんの有病率の増加
    • がん治療におけるデジタル化の進展
    • がん医療費削減ニーズの高まり
    • 電子カルテ(EHR)の採用増加
    • 合理化された患者情報とデータ管理に対する需要の増加
  • 抑制要因
    • がん情報システムの高コスト
    • データセキュリティとプライバシーに関する懸念
  • 機会
    • がん治療における精密医療の統合
    • 新興国における可能性
  • 課題
    • 導入と実施への障壁
    • がん情報システムを使用するためのトレーニングと教育の追加要件
  • 価格分析
  • 規制分析
  • ケーススタディ
  • 産業と技術の動向

第5章 がん情報システムの世界市場:製品別評価

  • 概要
  • ソフトウェア
    • 患者情報システム
    • 治療計画システム
  • サービス

第6章 がん情報システムの世界市場:用途別評価

  • 概要
  • 放射線がん
  • 医療がん
  • 外科がん

第7章 がん情報システムの世界市場:エンドユーザー別評価

  • 概要
  • 病院
  • 画像診断センター
  • がん治療センター
  • その他

第8章 がん情報システム市場:地域別評価

  • 概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他の欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他のアジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第9章 競合分析

  • 概要
  • 主要成長戦略
  • ベンダーベンチマーキング
  • 競合ダッシュボード
    • 業界リーダー
    • 市場差別化要因
    • 先行企業
    • 新興企業
  • 市場シェア分析(2022年)

第10章 企業プロファイル(企業概要、財務概要、製品ポートフォリオ、戦略的展開)

  • Accuray Incorporated
  • Brainlab AG
  • DOSIsoft SA
  • Elekta AB
  • Koninklijke Philips N.V.
  • MIM Software Inc.
  • Oracle Corporation
  • Prowess Inc.
  • RaySearch Laboratories
  • Siemens Healthcare GmbH
  • ViewRay Inc.
  • McKesson Corporation
  • Altai, Inc.

(注:主要企業5社のSWOT分析が報告書に掲載されます。)

第11章 付録

図表

LIST OF TABLES

  • Table 1 Global Oncology Information Systems Market Drivers: Impact Analysis (2024-2030)
  • Table 2 Global Oncology Information Systems Market Restraints: Impact Analysis (2024-2030)
  • Table 3 Global Oncology Information Systems Market Opportunities: Impact Analysis (2024-2030)
  • Table 4 Global Oncology Information Systems Market Challenges: Impact Analysis (2024-2030)
  • Table 5 Global Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 6 Global Oncology Information Systems Software Market, by Country/Region, 2021-2030 (USD Million)
  • Table 7 Global Oncology Information Systems Software Market, by Type, 2021-2030 (USD Million)
  • Table 8 Global Oncology Information Systems Services Market, by Country/Region, 2021-2030 (USD Million)
  • Table 9 Global Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 10 Global Oncology Information Systems Market for Medical Oncology, by Country/Region, 2021-2030 (USD Million)
  • Table 11 Global Oncology Information Systems Market for Radiation Oncology, by Country/Region, 2021-2030 (USD Million)
  • Table 12 Global Oncology Information Systems Market for Surgical Oncology, by Country/Region, 2021-2030 (USD Million)
  • Table 13 Global Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 14 Global Oncology Information Systems Market for Hospitals, by Country/Region, 2021-2030 (USD Million)
  • Table 15 Global Oncology Information Systems Market for Diagnostic Imaging Centers, by Country/Region, 2021-2030 (USD Million)
  • Table 16 Global Oncology Information Systems Market for Cancer Care Centers, by Country/Region, 2021-2030 (USD Million)
  • Table 17 Global Oncology Information Systems Market for Other End Users, by Country/Region, 2021-2030 (USD Million)
  • Table 18 Global Oncology Information Systems Market, by Country/Region, 2021-2030 (USD Million)
  • Table 19 North America: Oncology Information Systems Market, by Country, 2021-2030 (USD Million)
  • Table 20 North America: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 21 North America: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 22 North America: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 23 North America: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 24 U.S.: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 25 U.S.: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 26 U.S.: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 27 U.S.: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 28 Canada: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 29 Canada: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 30 Canada: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 31 Canada: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 32 Europe: Oncology Information Systems Market, by Country/Region, 2021-2030 (USD Million)
  • Table 33 Europe: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 34 Europe: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 35 Europe: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 36 Europe: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 37 Germany: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 38 Germany: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 39 Germany: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 40 Germany: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 41 U.K.: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 42 U.K.: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 43 U.K.: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 44 U.K.: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 45 France: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 46 France: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 47 France: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 48 France: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 49 Spain: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 50 Spain: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 51 Spain: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 52 Spain: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 53 Italy: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 54 Italy: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 55 Italy: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 56 Italy: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 57 Rest of Europe: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 58 Rest of Europe: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 59 Rest of Europe: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 60 Rest of Europe: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 61 Asia-Pacific: Oncology Information Systems Market, by Country/Region, 2021-2030 (USD Million)
  • Table 62 Asia-Pacific: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 63 Asia-Pacific: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 64 Asia-Pacific: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 65 Asia-Pacific: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 66 China: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 67 China: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 68 China: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 69 China: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 70 Japan: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 71 Japan: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 72 Japan: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 73 Japan: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 74 India: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 75 India: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 76 India: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 77 India: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 78 Rest of Asia-Pacific: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 79 Rest of Asia-Pacific: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 80 Rest of Asia-Pacific: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 81 Rest of Asia-Pacific: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 82 Latin America: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 83 Latin America: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 84 Latin America: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 85 Latin America: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 86 Middle East & Africa: Oncology Information Systems Market, by Offering, 2021-2030 (USD Million)
  • Table 87 Middle East & Africa: Oncology Information Systems Market Software, by Type 2021-2030 (USD Million)
  • Table 88 Middle East & Africa: Oncology Information Systems Market, by Application, 2021-2030 (USD Million)
  • Table 89 Middle East & Africa: Oncology Information Systems Market, by End User, 2021-2030 (USD Million)
  • Table 90 Recent Developments, by Company (2020-2024)

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Secondary Sources Referenced for this Study
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
  • Figure 6 Market Sizing and Growth Forecast Approach
  • Figure 7 Global Oncology Information Systems Market, by Offering, 2024 Vs. 2030 (USD Million)
  • Figure 8 Global Oncology Information Systems Market, by Application, 2024 Vs. 2030 (USD Million)
  • Figure 9 Global Oncology Information Systems Market, by End User, 2024 Vs. 2030 (USD Million)
  • Figure 10 Global Oncology Information Systems Market, by Geography
  • Figure 11 Market Dynamics: Oncology Information Systems Market
  • Figure 12 Global Oncology Information Systems Market, by Offering, 2024 Vs. 2030 (USD Million)
  • Figure 13 Global Oncology Information Systems Market, by Application, 2024 Vs. 2030 (USD Million)
  • Figure 14 Global Oncology Information Systems Market, by End User, 2024 Vs. 2030 (USD Million)
  • Figure 15 Global Oncology Information Systems Market, by Geography, 2024 Vs. 2030 (USD Million)
  • Figure 16 North America: Oncology Information Systems Market Snapshot
  • Figure 17 Europe: Oncology Information Systems Market Snapshot
  • Figure 18 Asia-Pacific: Oncology Information Systems Market Snapshot
  • Figure 19 Key Growth Strategies Adopted by Leading Players (2020-2024)
  • Figure 20 Global Oncology Information Systems Market: Vendor Benchmarking Based on Application
  • Figure 21 Global Oncology Information Systems Market: Vendor Benchmarking Based on Geography
  • Figure 22 Global Oncology Information Systems Market: Competitive Dashboard
  • Figure 23 Market Share Analysis: Oncology Information Systems Market (2022)
  • Figure 24 Accuray Incorporated: Financial Overview (2022)
  • Figure 25 Brainlab AG: Financial Overview (2022)
  • Figure 26 Koninklijke Philips N.V.: Financial Overview (2022)
  • Figure 27 Elekta AB: Financial Overview (2022)
  • Figure 28 Oracle Corporation: Financial Overview (2022)
  • Figure 29 RaySearch Laboratories: Financial Overview (2022)
  • Figure 30 Siemens Healthcare GmbH: Financial Overview (2022)
  • Figure 31 McKesson Corporation: Financial Overview (2022)
  • Figure 32 Altai, Inc: Financial Overview (2022)
目次
Product Code: MRHC - 104908

Oncology Information Systems Market Size, Share, Forecast, & Trends Analysis by Offering (Software {Patient Information, Treatment Planning}, Services), Application (Surgical, Radiology Oncology), End User (Hospital, Cancer Care) - Global Forecast to 2030

The oncology information systems market is projected to reach $4.45 billion by 2030 at a CAGR of 7.4% from 2023 to 2030.

Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report provides an analysis of key industry drivers, restraints, opportunities, and challenges.

The growth of this market is driven by the increasing prevalence of cancer, rising digitalization in cancer treatment, the growing need to reduce oncology care costs, the increasing adoption of Electronic Health Records (EHR), and the growing demand for streamlined patient information and data management.

However, the high cost of oncology information systems and data security and privacy concerns are restraining the growth of this market. In addition, the integration of precision medicine into cancer treatment and its growing potential in emerging countries are expected to generate significant growth opportunities for the players in this market.

However, barriers to the adoption and implementation of oncology information systems and additional requirements for training and education for using oncology information systems are major challenges limiting the market's growth.

The report offers a competitive landscape based on an extensive assessment of the product portfolios, geographic presence, and key strategic developments of leading market players during the last four years (2020-2023). The key players operating in the oncology information systems market are Accuray Incorporated (U.S.), Brainlab AG (Germany), DOSIsoft SA (France), Elekta AB (Sweden), Koninklijke Philips N.V. (Netherlands), MIM Software Inc. (U.S.), Oracle Corporation (U.S.), Prowess Inc. (U.S.), RaySearch Laboratories (Sweden), Siemens Healthcare GmbH (Germany), McKesson Corporation (U.S.), Altai, Inc (Turkey), and ViewRay Inc. (U.S.).

Based on offering the oncology information systems market is segmented into software and services. In 2023, the software segment is expected to account for the larger share of the oncology information systems market. The large share of this segment is attributed to the increased need to streamline patient data, the high prevalence of cancer, and the benefits of advanced features of oncology information systems such as management of patient treatment schedules, treatment plans, treatment delivery, and treatment summaries.

Based on application, the oncology information systems market is segmented into medical oncology, radiation oncology, and surgical oncology. In 2023, the medical oncology segment is expected to account for the largest share of the oncology information systems market. The large market share of this segment is attributed to the large number of patients receiving medical oncology treatments such as chemotherapy, immunotherapy, hormone therapy, and targeted therapy.

Based on end user, the oncology information systems market is segmented into hospitals, diagnostic imaging centers, cancer care centers, and other end users. In 2023, the hospitals segment is expected to account for the largest share of the oncology information systems market. The large market share of this segment is attributed to high healthcare expenditure, increased capability of hospitals to purchase and implement oncology information systems, and increased number of cancer patients relying on hospitals for treatment.

An in-depth analysis of the geographical scenario in the oncology information systems market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the oncology information systems market. North America's major market share is primarily attributed to the robust healthcare infrastructure, high healthcare expenditure, large patient population, high adoption of precision medicine, and the presence of key market players in the region.

Scope of the Report:

Oncology Information Systems Market Assessment-by Offering

  • Software
    • Patient Information Systems
    • Treatment Planning Systems
  • Services

Oncology Information Systems Market Assessment-by Application

  • Radiation Oncology
  • Medical Oncology
  • Surgical Oncology

Oncology Information Systems Market Assessment-by End User

  • Hospitals
  • Diagnostic Imaging Centers
  • Cancer Care Centers
  • Other End Users

Note: Other end users primarily include research institutes and government institutions.

Oncology Information Systems Market Assessment-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency and Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
  • 2.3. Market Sizing and Forecast
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
    • 2.3.3. Market Share Analysis
  • 2.4. Assumptions for this Study

3. Executive Summary

4. Market Insights

  • 4.1. Market Overview
  • 4.2. Drivers
    • 4.2.1. Increasing Prevalence of Cancer
    • 4.2.2. Rising Digitalization in Cancer Treatment
    • 4.2.3. Rising Need to Reduce Oncology Care Costs
    • 4.2.4. Increasing Adoption of Electronic Health Records (EHRs)
    • 4.2.5. Increased Demand for Streamlined Patient Information and Data Management
  • 4.3. Restraints
    • 4.3.1. High Cost of Oncology Information Systems
    • 4.3.2. Data Security and Privacy Concerns
  • 4.4. Opportunities
    • 4.4.1. Integration of Precision Medicine for Cancer Treatment
    • 4.4.2 Potential in Emerging Countries
  • 4.5. Challenges
    • 4.5.1. Barriers to Adoption and Implementation
    • 4.5.2. Additional Requirement for Training and Education for Using Oncology Information Systems
  • 4.6. Pricing Analysis
  • 4.7. Regulatory Analysis
  • 4.8. Case Studies
  • 4.9. Industry & Technology Trends

5. Global Oncology Information Systems Market Assessment-by Offering

  • 5.1. Overview
  • 5.2. Software
    • 5.2.1. Patient Information Systems
    • 5.2.2. Treatment Planning Systems
  • 5.3. Services

6. Global Oncology Information Systems Market Assessment-by Application

  • 6.1. Overview
  • 6.2. Radiation Oncology
  • 6.3. Medical Oncology
  • 6.4. Surgical Oncology

7. Global Oncology Information Systems Market Assessment-by End User

  • 7.1. Overview
  • 7.2. Hospitals
  • 7.3. Diagnostic Imaging Centers
  • 7.4. Cancer Care Centers
  • 7.5. Other End Users

8. Oncology Information Systems Market Assessment-by Geography

  • 8.1. Overview
  • 8.2. North America
    • 8.2.1. U.S.
    • 8.2.2. Canada
  • 8.3. Europe
    • 8.3.1. Germany
    • 8.3.2. U.K.
    • 8.3.3. France
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Rest of Europe
  • 8.4. Asia-Pacific
    • 8.4.1. China
    • 8.4.2. Japan
    • 8.4.3. India
    • 8.4.4. Rest of Asia-Pacific
  • 8.5. Latin America
  • 8.6. Middle East & Africa

9. Competition Analysis

  • 9.1. Overview
  • 9.2. Key Growth Strategies
  • 9.3. Vendor Benchmarking
  • 9.4. Competitive Dashboard
    • 9.4.1. Industry Leaders
    • 9.4.2. Market Differentiators
    • 9.4.3. Vanguards
    • 9.4.4. Emerging Companies
  • 9.5. Market Share Analysis (2022)

10. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)

  • 10.1. Accuray Incorporated
  • 10.2. Brainlab AG
  • 10.3. DOSIsoft SA
  • 10.4. Elekta AB
  • 10.5. Koninklijke Philips N.V.
  • 10.6. MIM Software Inc.
  • 10.7. Oracle Corporation
  • 10.8. Prowess Inc.
  • 10.9. RaySearch Laboratories
  • 10.10. Siemens Healthcare GmbH
  • 10.11. ViewRay Inc.
  • 10.12. McKesson Corporation
  • 10.13. Altai, Inc.

(Note: SWOT Analysis Of The Top 5 Players Will Be Provided In The Report)

11. Appendix

  • 11.1. Available Customization
  • 11.2. Related Reports